Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remifentanil in capsaicin-induced hyperalgesia
NCT00789386Phase 4Unknown
- Sponsor
- Medical University of Vienna
- Start
- Nov 2008
- Primary completion
- Oct 2009
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of remifentanil in hyperalgesia, sponsored by Medical University of Vienna. Primary endpoint: Area of pin prick hyperalgesia. Status: unknown.
02
Drugs
remifentanil
03
Conditions
hyperalgesia
Beyond the preview
Go deeper on NCT00789386.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00789386.